Digital Platform Caresyntax Extends Series C To Total $130M Raised
Executive Summary
Caresyntax raised $130m in total funding to expand commercialization of its software that seeks to reduce variability and improve outcomes in the operating room.
You may also be interested in...
Digital Health Roundup, April 2021: Digital Transformation In OR, Clinical Trials, Remote Monitoring
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from April.
De Oro Devices’ Nex(t)Stride To Help Freezing Gait Is Expand Into Other Diseases, Add Software
De Oro Devices’ plans to add more indications for its portable device for freezing gait associated with Parkinson’s disease. In 2023, the company hopes to address , multiple sclerosis, stroke and cerebral palsy, and add mobility-gait software.
MedRhythms On First-To-Market Track With Prescription Music Therapy For Chronic Stroke
MedRhythms’ digital therapeutics platform aims to improve walking and functional outcomes in patients with multiple sclerosis, Parkinsons’ disease and chronic stroke. With around $32m in funding to date, the start-up boasts collaborations with major medical centers and a partnership with Biogen.